{"id":534285,"date":"2021-03-16T18:48:01","date_gmt":"2021-03-16T18:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=534285"},"modified":"2021-03-16T18:48:01","modified_gmt":"2021-03-16T18:48:01","slug":"comprehensive-epidemiology-insight-of-the-presbyopia-its-treatment","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/comprehensive-epidemiology-insight-of-the-presbyopia-its-treatment_534285.html","title":{"rendered":"Comprehensive epidemiology insight of the Presbyopia &#038; its treatment"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1615885791.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Comprehensive epidemiology insight of the Presbyopia &amp; its treatment\" src=\"https:\/\/www.abnewswire.com\/uploads\/1615885791.png\" alt=\"Comprehensive epidemiology insight of the Presbyopia &amp; its treatment\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\">DelveInsight has launched a new report on <span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/presbyopia-epidemiology-forecast?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>Presbyopia Epidemiology<\/strong><\/a><\/span><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">About <strong>Presbyopia Disease<\/strong><\/p>\n<p style=\"text-align: justify;\">Presbyopia is the normal loss of near focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. It is a result of a gradual decrease in accommodative amplitude, from about 15 diopters (D) to 1 D. This typically comes on between the ages of 40 and 60 as the lenses of the eyes naturally lose elasticity due to the aging process.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample copy- <span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/presbyopia-epidemiology-forecast?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/presbyopia-epidemiology-forecast <\/a><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Presbyopia Epidemiology <\/strong><\/p>\n<p style=\"text-align: justify;\">Presbyopia is a vision condition in which the shape of the crystalline lens of the eye changes. These changes make it difficult to focus on close objects. Presbyopia usually becomes visible in the early to mid-40s, but the reduction in the vision of an individuals&rsquo; focus starts as early as childhood.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Important facts of Presbyopia Epidemiology report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The prevalence rate of presbyopia ranged from 83.0% to 88.9% for adults aged &gt;45 years<\/li>\n<li>The prevalence rate of presbyopia was approximately 83% in the case of the United States.<\/li>\n<li>Presbyopia patients estimated by the American Optometric Association can also be seen in a similar range. According to the association, presbyopia was expected to impact approximately 123 million US residents by 2020<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Presbyopia Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalent Cases of 7MM (2018&ndash;2030)<\/li>\n<li>Age-Specific Cases of Presbyopia in the 7MM (2018&ndash;2030)<\/li>\n<li>Severity-specific Cases of Presbyopia in the 7MM (2018&ndash;2030)<\/li>\n<li>Treated cases of Presbyopia in the 7MM (2018&ndash;2030)<\/li>\n<li>Gender-specific Cases of Presbyopia in the Total Prevalent Cases of 7MM (2018&ndash;2030)<\/li>\n<li>Total Diagnosed Cases of Presbyopia in the 7MM (2018&ndash;2030)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/presbyopia-epidemiology-forecast?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>Presbyopia Prevalent Population<\/strong><\/a><\/span><\/p>\n<p style=\"text-align: justify;\">The prevalence of functional presbyopia at baseline was 25.2% (95% CI 21.5&ndash;28.9). Older and more hyperopic subjects had a higher prevalence of presbyopia (p &lt; 0.001). Average presbyopic correction coverage (PCC) was 87.7% at baseline and was significantly lower in myopic participants (p = 0.006).<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Presbyopia Epidemiology: Report Scope<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Presbyopia report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns<\/li>\n<li>The Presbyopia Epidemiology Report and Model provide an overview of the risk factors and global trends of Presbyopia in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)<\/li>\n<li>The report provides insight about the historical and forecasted patient pool of Presbyopia in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan<\/li>\n<li>The report helps to recognize the growth opportunities in the 7MM with respect to the patient population<\/li>\n<li>The report assesses the disease risk and burden and highlights the unmet needs of Presbyopia<\/li>\n<li>The report provides the segmentation of the Presbyopia epidemiology<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample copy- <span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/presbyopia-epidemiology-forecast?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/presbyopia-epidemiology-forecast <\/a><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Following is the table of content of Presbyopia Epidemiology Report<\/strong><\/p>\n<p style=\"text-align: justify;\">1.&nbsp;Key Insights&nbsp;<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Presbyopia<\/p>\n<p style=\"text-align: justify;\">3.&nbsp;Presbyopia: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">4.&nbsp;Patient Journey<\/p>\n<p style=\"text-align: justify;\">5.&nbsp;Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">6.&nbsp;Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">7.&nbsp;KOL Views<\/p>\n<p style=\"text-align: justify;\">8.&nbsp;Unmet Needs<\/p>\n<p style=\"text-align: justify;\">9.&nbsp;&nbsp;Appendix<\/p>\n<p style=\"text-align: justify;\">10.&nbsp;DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">11.&nbsp;Disclaimer<\/p>\n<p style=\"text-align: justify;\">12.&nbsp;About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>What are the important reasons to buy this report?<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Develop business strategies by understanding the trends shaping and driving the global Presbyopia market<\/li>\n<li>Quantify patient populations in the global Presbyopia market to improve product design, pricing, and launch plans<\/li>\n<li>Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Presbyopia therapeutics in each of the markets covered<\/li>\n<li>Understand the magnitude of Presbyopia population by its epidemiology<\/li>\n<li>The Presbyopia Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/presbyopia-market\" target=\"_blank\">Presbyopia&nbsp;Market<\/a><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56402.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Yash Bhardwaj<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=comprehensive-epidemiology-insight-of-the-presbyopia-its-treatment\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=comprehensive-epidemiology-insight-of-the-presbyopia-its-treatment\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight has launched a new report on Presbyopia Epidemiology &nbsp; About Presbyopia Disease Presbyopia is the normal loss of near focusing ability that occurs with age. Most people begin to notice the effects of presbyopia sometime after age 40. It &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/comprehensive-epidemiology-insight-of-the-presbyopia-its-treatment_534285.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,417,406,423],"tags":[],"class_list":["post-534285","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/534285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=534285"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/534285\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=534285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=534285"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=534285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}